Mastercard 'preying on millions' sparked £$14b fee lawsuit
[LONDON] Mastercard Inc preyed on more than 46 million unknowing consumers by unfairly charging card fees over a 16-year period, lawyers seeking to bring a £14 billion (S$24.53 billion) class-action lawsuit told a London court.
The credit-card company infringed European Union competition law by imposing high charges to retailers that accepted its cards between 1992 and 2008, Paul Harris, a lawyer for consumers, told the Competition Appeal Tribunal Wednesday. The panel will hold a two-day hearing to decide whether the matter should go to a full trial. It would be the UK's biggest class action and one of the first filed under the Consumer Rights Act 2015."It is difficult to be able to see why Mastercard should be able to prey on millions of people, what's more without these people knowing they were being injured," Mr Harris said. "This is the archetypal case that the government had in mind when creating this new regime." Mastercard has faced numerous lawsuits since EU courts said the company's fees for cross-border payments unfairly restricted competition. The firm said that a cap imposed by the European Commission on what it charged retailers to process transactions on foreign transactions would shift the burden onto customers, an argument the Court of Justice rejected and opened the door to collective lawsuits from consumers.
The lawsuit was initiated by Walter Merricks, a lawyer who once led the UK organization that handles consumer disputes with banks, and Quinn Emanuel Urquhart & Sullivan LLP.
In court documents, Mastercard said the suit should be rejected because the level of damages is "impossible to assess on any reliable basis." The awards allocated to individuals would also "bear no reasonable relationship to their actual loss," the company said."Mastercard continues to disagree with the basis of the proposed collective action and we will strongly oppose this claim in the event the court decides to hear the case," a spokesman said.
BLOOMBERG
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue